![]() |
SiMPore's 15 nanometer thick ultrathin membrane enables precise and rapid separation of biological molecules and other nanomaterials. |
Abstract:
SiMPore, Inc. has been selected to present at the upcoming NSTI Nanotech Ventures in Boston, June 3-5, 2008. Mr. Thomas Gaborski, Co-Founder and Vice President of Business Development for SiMPore, provided us with several update on the company and recent funding and development news.
CEO: Rick Richmond
Location: New York, USA
Industry: Pharma & Biotech
Venture is: Seed Level
SiMPore develops and produces ultra-thin nano-porous membrane filters and filtration products based on a new silicon membrane platform technology.
Membranes and membrane filters in use today are based on technology that dates from the mid-20th century. These filters are adequate for the microporous (one millionth of a meter) and submicroporous filtration for which they were initially developed.
With the advance of technology, biomedical research, pharmaceutical production and even industrial and consumer products have come to rely on nanoscale building blocks. Viruses, genes, proteins and nanoparticles are the new frontier. The need for filtration has expanded to include filtering and separating nanomaterials, not only for research and production, but also to protect from nanoparticle contamination in industrial processes and eliminating bio- and chemical hazards. Conventional polymer microporous membrane technology has attempted to address these needs for nanoporous filtration by tweaking microporous technology, but have not addressed many needs of the nano-world.
Mr. Gaborski tells the Nano World News that SiMPore is exclusively licensing this novel silicon membrane technology from the University of Rochester, where researchers and SiMPore co-founders have received over $1.5M in federal funding in the previous 12 months. In addition, SiMPore and the University of Rochester were awarded $473,000 in February by NYSTAR for the co-development and commercialization of SiMPore's porous silicon membrane for biomolecule filtration.
SiMPore is also pursuing industrial collaboration and is engaged in co-development talks with major filtration companies.
Currently, SiMPore is raising $500,000 in an angel round and expects to seek an A-round in 2009.
####
About NSTI
The Nano Science and Technology Institute (NSTI) is chartered with the promotion and integration of nano and other advanced technologies through education, technology and business development. NSTI accomplishes this mission through its offerings of continuing education programs, scientific and business publishing and community outreach. NSTI produces the annual Nanotech conference and trade show, the most comprehensive international nanotechnology convention in the world. NSTI also produces the semi-annual Nanotech Venture, Nanotech Industrial Impact Workshop, Nano Impact Summit and the Nanotech Course Series in the US and Europe. NSTI was founded in 1997 as a result of the merger between various scientific societies, and is headquartered in Cambridge, Massachusetts with additional offices in California and Switzerland.
For more information, please click here
Contacts:
Sarah Wenning
696 San Ramon Valley Blvd., Ste. 423
Danville, CA 94526
Ph: (925) 901-4959
Fax: (925) 886-8461
Copyright © NSTI
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
New organic molecule shatters phosphorescence efficiency records and paves way for rare metal-free applications July 5th, 2024
Single atoms show their true color July 5th, 2024
New method cracked for high-capacity, secure quantum communication July 5th, 2024
Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024
VC/Funding/Angel financing/Loans/Leases/Crowdfunding
Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024
Advances in priming B cell immunity against HIV pave the way to future HIV vaccines, shows quartet of new studies May 17th, 2024
Announcements
New organic molecule shatters phosphorescence efficiency records and paves way for rare metal-free applications July 5th, 2024
Single atoms show their true color July 5th, 2024
New method cracked for high-capacity, secure quantum communication July 5th, 2024
Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |